About Cubit Lifesciences LLP
Data last updated:
Cubit Lifesciences LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAM-8820. Its GSTIN is 24AANFC6646D1ZH (Gujarat). The LLP holds 2 GST registrations, all of them active.
The LLP has a total obligation of contribution of ₹3 Cr. It is led by designated partners including Ashok Kumar Agrawal and Prabhat Agrawal.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹76.66 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Cr (net margin 1.4%) and EBITDA of ₹5.96 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
The LLP has about 70 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Cubit Lifesciences. As per MCA filings, the LLP has open charges of ₹49.96 Cr on record. Court records list 3 cases involving the LLP, including 2 filed by the LLP; 2 cases are pending.
For more details, the LLP can be reached via its website cubitlifescience.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No 13/369 Panchratna Industrial Estate Sarkhej – Bavla Highway At. Changodar Ta, . Sanand, Ahmedabad, Gujarat, India – 380013
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Cubit Lifesciences LLP FY 2025 filings available
Cubit Lifesciences LLP reported revenue of ₹76.66 Cr (down 2% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Cubit Lifesciences LLP
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cubit Lifesciences LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹76.66 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹1.05 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cubit Lifesciences LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Cubit Lifesciences are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cubit Lifesciences LLP
Cubit Lifesciences LLP is compared with the companies closest to it by revenue in the Pharma industry (Lifesciences). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cubit Lifesciences LLP this company | ₹76.66 Cr (FY 2023) | •••• | •••• | -2.0% | •••• | Ahmedabad, Gujarat, India |
| Aegis Lifesciences Private Limited | ₹73.4 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Ahmedabad, Gujarat, India |
| Levram Lifesciences Private Limited | ₹72.95 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Arinna Lifesciences Limited | ₹72.24 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Jaahnavee Lifesciences Private Limited | ₹70.16 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Jay Jalaram Lifesciences Private Limited | ₹68.5 Cr (FY 2025) | •••• | •••• | 212.0% | •••• | Ankleshwar, Gujarat, India |
| Sahs Lifesciences Private Limited | ₹66.05 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Karnal, Haryana, India |
| Juvencia Lifesciences Private Limited | ₹65.88 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Ahmedabad, Gujarat, India |
| Matrix Lifesciences Private Limited | ₹62.71 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Raipur, Chhattisgarh, India |
| Shamshree Lifesciences Limited | ₹62.27 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Yacca Lifesciences Private Limited | ₹60.81 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Roorkee, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Cubit Lifesciences by revenue in the Pharma industry (Lifesciences), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Designated Partners of Cubit Lifesciences LLP
Cubit Lifesciences has 5 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Kumar Agrawal Also directs: Cubit Formulations Private Limited | Designated Partner | 28 Jun 2018 | 8 Years 3 Months | Current |
| Prabhat Agrawal Also directs: Cubit Formulations Private Limited, Cubit Medisurge LLP, Cusan Apis Private Limited and 1 more | Designated Partner | 28 Jun 2018 | 8 Years 3 Months | Current |
| Shalini Ravi Agrawal | Designated Partner | 05 Oct 2018 | 8 Years 0 Months | Current |
| Priyanka Prabhat Agrawal Also directs: Cubit Formulations Private Limited | Designated Partner | 05 Oct 2018 | 8 Years 0 Months | Current |
| Ravi Ashokkumar Agrawal | Designated Partner | 24 Aug 2023 | 3 Years 1 Months | Current |
Ownership and Shareholding of Cubit Lifesciences LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cubit Lifesciences LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2019 | State Bank of India | ₹24.98 Cr | Open |
| 03 May 2019 | State Bank of India | ₹24.98 Cr | Open |
Total charge records: 2 View all charges
Legal Cases of Cubit Lifesciences LLP
Cubit Lifesciences LLP has 3 court cases on record: 2 filed by Cubit Lifesciences, 1 where it is another party. 2 cases are pending and 1 is disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jalpaiguri, West Bengal | Civil suit | Company is another party | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| High Court of Gujarat | Special civil application | Filed by the company against an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Cubit Lifesciences LLP
Cubit Lifesciences operates one associated brand: Cubit Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical formulation research and development services. | cubitlifescience.com |
Employees and EPFO Compliance at Cubit Lifesciences LLP
Cubit Lifesciences LLP has a workforce of 70 employees as of Mar 29, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cubit Lifesciences LLP
Cubit Lifesciences LLP has 6 designated partner changes on record since 2018: 5 appointments and 1 cessation. The latest: Ravi Ashokkumar Agrawal was appointed as Designated Partner on 24 Aug 2023.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Cubit Lifesciences LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cubit Lifesciences LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cubit Lifesciences LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cubit Lifesciences LLP
Cubit Lifesciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AANFC6646D1ZH | Gujarat | Active | 25 Sep 2018 |
| 24AANFC6646D2ZG | Gujarat | Active | 22 Nov 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cubit Lifesciences LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cubit Lifesciences LLP
Cubit Lifesciences is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2018 (8+ years old) and is registered under LLPIN AAM-8820.
Cubit Lifesciences reported revenue of ₹76.66 Cr for FY 2023 (down 2% YoY).
Cubit Lifesciences has 5 current designated partners:
- Ashok Kumar Agrawal - Designated Partner
- Prabhat Agrawal - Designated Partner
- Shalini Ravi Agrawal - Designated Partner
- Priyanka Prabhat Agrawal - Designated Partner
- Ravi Ashokkumar Agrawal - Designated Partner
Cubit Lifesciences reported a net profit of ₹1.05 Cr (net margin 1.4%) and EBITDA of ₹5.96 Cr (EBITDA margin 7.8%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cubit Lifesciences is 15% over three years. In the latest year (FY 2023) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cubit Lifesciences is 24AANFC6646D1ZH, registered in Gujarat. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AANFC6646D2ZG (Gujarat).
The LLPIN (Limited Liability Partnership Identification Number) of Cubit Lifesciences is AAM-8820. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Cubit Lifesciences has 3 court cases on record: 2 filed by the LLP. 2 are pending. Most are in the district courts.
Cubit Lifesciences was incorporated on 28 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Cubit Lifesciences by revenue are Aegis Lifesciences Private Limited, Levram Lifesciences Private Limited, Arinna Lifesciences Limited, Jaahnavee Lifesciences Private Limited, Jay Jalaram Lifesciences Private Limited and 5 more, all in the Pharma industry (Lifesciences).
Ravi Ashokkumar Agrawal was appointed as Designated Partner on 24 Aug 2023. Ravi Ashokkumar Agrawal ceased to be Designated Partner on 19 Feb 2019. Priyanka Prabhat Agrawal was appointed as Designated Partner on 05 Oct 2018. Cubit Lifesciences has 6 designated partner changes on record in total.